clinical trial · NCT06386744
Dusquetide for the Treatment of Behcet's Disease
Soligenix·phase2·completed·n = 8
Behçet DiseaseDusquetide
brief summary
This is a clinical study to see if dusquetide can treat flares of oral and genital ulcers caused by Behcet's Disease. Study participants will receive an infusion of dusquetide twice a week for 4 weeks (8 treatments total), with weekly follow-up visits for an additional 4 weeks.
started
Nov 18, 2024
primary completion
May 23, 2025
completion
Jun 17, 2025
last updated
Aug 1, 2025
official title
Pilot Study of SGX945 (Dusquetide) in the Treatment of Aphthous Ulcers in Behcet's Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol